This gene mutation involves HCN2, LOC129391015 (hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2| MPRA-validated peak3211 silencer) on Chromosome 19. Is it associated with any clinical condition, or is it benign?
Pathogenic; HCN2 related developmental and epileptic encephalopathy